Similar articles

• [Novel targets for cancer chemotherapy].

  Inoue S. Inoue S. Gan To Kagaku Ryoho. 1996 Jan;23(2):191-201. Gan To Kagaku Ryoho. 1996. PMID: 8611047 Review. Japanese.
• Preclinical and clinical development of novel agents that target the protein kinase C family.

  Serova M, Ghoul A, Benhadji KA, Cvitkovic E, Faivre S, Calvo F, Lokiec F, Raymond E. Serova M, et al. Semin Oncol. 2006 Aug;33(4):466-78. doi: 10.1053/j.seminoncol.2006.04.009. Semin Oncol. 2006. PMID: 16890801 Review.
• New targets for cancer chemotherapy.

  Arbuck SG, Dancey J, Pluda JM, Grochow L, Murgo AJ, Ivy P, Wright J, Blaylock B, Via LE, Sausville EA. Arbuck SG, et al. Cancer Chemother Biol Response Modif. 2001;19:237-88. Cancer Chemother Biol Response Modif. 2001. PMID: 11686017 Review. No abstract available.
• Tumor cell metabolism: cancer's Achilles' heel.

  Kroemer G, Pouyssegur J. Kroemer G, et al. Cancer Cell. 2008 Jun;13(6):472-82. doi: 10.1016/j.ccr.2008.05.005. Cancer Cell. 2008. PMID: 18538731 Review.
• Telomerase inhibition, oligonucleotides, and clinical trials.

  Corey DR. Corey DR. Oncogene. 2002 Jan 21;21(4):631-7. doi: 10.1038/sj.onc.1205063. Oncogene. 2002. PMID: 11850789 Review.